Most Read Articles
14 Dec 2017
The coexistence of fibromyalgia in patients with axial spondyloarthritis (axSpA) exerts a negative effect on response to tumour necrosis factor blocker, according to a study. This effect appears to be associated with the self-reported instruments used in fibromyalgia evaluation rather than a different treatment effect of the agent in this population.

Vitamin D deficiency implicated in functional disability in RA

02 Jun 2019

Vitamin D deficiency in patients with rheumatoid arthritis (RA) may contribute to functional disability but exerts no effect on disease activity or inflammatory markers, a recent study from Malaysia has found.

The study population comprised 100 RA patients (mean age, 48.2 years; 92 percent female) and 50 matched healthy controls (mean age, 45.2 years; 90 percent female). Researchers measured baseline serum 25(OH)D3 and interleukin (IL)-6 levels, as well as assessed Disease Activity Score of 28 joints and Health Assessment Questionnaire (HAQ) scores.

Sixty-three percent of RA patients and 76 percent of controls were vitamin D deficient (25[OH]D <50 nmol/L). In the RA group, significantly more Chinese patients had sufficient 25(OH)D3 levels than Malay and Indian patients (p<0.001 for both).

Serum 25(OH)D3 level inversely correlated with body mass index in RA patients (p=0.002) but not in controls (p=0.419).

All participants with vitamin D deficiency received loading doses of vitamin D3. There was no significant association observed between 25(OH)D3 levels and disease activity or serum IL-6 levels both at baseline and after treatment.

On the other hand, low serum 25(OH)D3 concentration was associated with functional disability at baseline, and vitamin D treatment yielded a 33-percent improvement in mean HAQ score (from 0.30 to 0.20).

The results suggest that vitamin D deficiency is prevalent in Malaysian RA patients and plays a role in functional disability. However, researchers admitted that the HAQ score reflects a subjective rather than an objective outcome measure and therefore could have been related to generalized musculoskeletal pain or chronic pain.

Additional studies are needed to confirm the role of vitamin D in mediating cytokines such as IL‐6 in the pathomechanism of RA, researchers added.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Rheumatology digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
14 Dec 2017
The coexistence of fibromyalgia in patients with axial spondyloarthritis (axSpA) exerts a negative effect on response to tumour necrosis factor blocker, according to a study. This effect appears to be associated with the self-reported instruments used in fibromyalgia evaluation rather than a different treatment effect of the agent in this population.